USPTO serial 79358195
BIOCONNECTION
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Nov 26, 2024
- Examiner
- BARRETT, LEAH N
- Law office
- TMEG LAW OFFICE 106
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with BIOCONNECTION?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical additives for use in manufacturing of pharmaceuticals; chemical additives for use in the manufacture of medicaments; chemicals used in industry and science; active chemical ingredients for use in the manufacture of pharmaceuticals for treating cardiovascular disorders, for treating diabetes, for treating allergies, for treating hypertension, for treating asthma, for use in urology, for use in dermatology, for treating skin disorders, for peripheral nervous system, for use in chemotherapy, for the treatment of hyperlipidemia, for the central nervous system, for treatment of infectious diseases, for the treatment of viral diseases, for the treatment of autoimmune diseases, for the treatment of musculo-skeletal disorders, for the treatment of gastro-intestinal diseases, for the treatment of immune system related diseases and disorders, kidney diseases or disorders, and diabete | ACTIVE | — |
| 005 | Medicines and pharmaceutical preparations, namely, for treatment of cardiovascular disorders, for treating diabetes, for treating allergies, for treating hypertension, for treating asthma, for use in urology, for use in dermatology, for treating skin disorders, for peripheral nervous system, for use in chemotherapy, for the treatment of hyperlipidemia, for the central nervous system, for treatment of infectious diseases, for the treatment of viral diseases, for the treatment of autoimmune diseases, for the treatment of musculo-skeletal disorders, for the treatment of gastro-intestinal diseases, for the treatment of immune system related diseases and disorders, kidney diseases or disorders, and diabetes; dietary supplements for humans and animals | ACTIVE | — |
| 035 | Business consultancy services relating to manufacturing of medicinal and pharmaceutical preparations; business management advice relating to manufacturing business; advertising services; business management | ACTIVE | — |
| 040 | Contract manufacturing services in the field of preparing medicines and pharmaceutical products; custom manufacturing of biopharmaceuticals; custom manufacturing of pharmaceutical products, namely, for treatment of cardiovascular disorders, for treating diabetes, for treating allergies, for treating hypertension, for treating asthma, for use in urology, for use in dermatology, for treating skin disorders, for peripheral nervous system, for use in chemotherapy, for the treatment of hyperlipidemia, for the central nervous system, for treatment of infectious diseases, for the treatment of viral diseases, for the treatment of autoimmune diseases, for the treatment of Musculo-skeletal disorders, for the treatment of gastro-intestinal diseases, for the treatment of immune system related diseases and disorders, kidney diseases or disorders, and diabetes; preparing medicines and pharmaceutical products being contract manufacturing services, also with the aid of biotechnology | ACTIVE | — |
| 042 | Product research and development; research and development in the pharmaceutical and biotechnology field; research and development of new products for others; development of pharmaceutical preparations and medicines; services of bio technical, chemical and pharmaceutical laboratories, including scientific and technological research relating to the production of chemicals and biotechnological products for use in preparing pharmaceutical and veterinary preparations, as well as providing expert advice in the field of pharmaceutical and veterinary preparations; carrying out early evaluations in the field of new medicines as part of scientific research; development of pharmaceutical preparations, medicines and medicaments; evaluation of pharmaceutical products as part of scientific analysis and research; research and development in the pharmaceutical field; advice regarding the aforesaid research, development and analysis services as part of consultations about medicines; advice regarding scientific research and analysis relating to medicines; information with regard to scientific research in the field of biochemistry and biotechnology; scientific research, including in the medical sector | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by BioConnection B.V.
- Other trademarks owned by BioConnection B.V.
- Other trademarks owned by BioConnection B.V.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 035
- Other trademarks in Class 040
- Other trademarks in Class 042
- Similar marks named BIOCONNECTION
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 16, 2026 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 30, 2026 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Mar 30, 2026 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Dec 19, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 18, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 26, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Nov 26, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 3, 2024 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| Jul 23, 2024 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Jun 25, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 25, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 5, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 23, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 14, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 13, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 13, 2024 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jan 30, 2024 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jan 30, 2024 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 30, 2024 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 30, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 22, 2023 | RFNP | REFUSAL PROCESSED BY IB | — |
| Jul 15, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 14, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 14, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 26, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 25, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| May 19, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 18, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 12, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 17, 2023 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jan 17, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jan 17, 2023 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Jan 17, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 17, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 17, 2023 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Dec 27, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 23, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 22, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |